Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?
Shelly Pathania, Pankaj Kumar Singh · Expert Opinion on Drug Metabolism & Toxicology · 2020
In this era, rational drug designing protocols involve an in-silico virtual screening process of evaluating a library of molecular structures to enhance the speed of the drug discovery process [1]....